Weekly Recap | AstraZeneca -1.56%, breast cancer miss weighsWeekly Review·Sep 12 at 07:44 AMAZN+0.85%
Weekly Recap | AstraZeneca flat, oncology trial and EU approval dominateWeekly Review·Sep 5 at 06:11 AMAZN+0.85%
Weekly Recap | AstraZeneca -1.98%, consensus target above spotWeekly Review·Aug 29 at 05:16 AMAZN+0.85%
